These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19799612)

  • 1. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.
    Maeda N; Muta H; Oflazoglu E; Yoshikai Y
    Cancer Sci; 2010 Jan; 101(1):224-30. PubMed ID: 19799612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
    Nakashima M; Uchimaru K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
    Wahl AF; Klussman K; Thompson JD; Chen JH; Francisco LV; Risdon G; Chace DF; Siegall CB; Francisco JA
    Cancer Res; 2002 Jul; 62(13):3736-42. PubMed ID: 12097283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.
    Cerveny CG; Law CL; McCormick RS; Lenox JS; Hamblett KJ; Westendorf LE; Yamane AK; Petroziello JM; Francisco JA; Wahl AF
    Leukemia; 2005 Sep; 19(9):1648-55. PubMed ID: 16049514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.
    Okudaira T; Tomita M; Uchihara JN; Matsuda T; Ishikawa C; Kawakami H; Masuda M; Tanaka Y; Ohshiro K; Takasu N; Mori N
    Mol Cancer Ther; 2006 Mar; 5(3):704-12. PubMed ID: 16546985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals.
    Nakashima M; Yamochi T; Watanabe M; Uchimaru K; Utsunomiya A; Higashihara M; Watanabe T; Horie R
    Clin Cancer Res; 2018 Nov; 24(21):5445-5457. PubMed ID: 30068708
    [No Abstract]   [Full Text] [Related]  

  • 8. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
    Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
    FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30.
    Oflazoglu E; Stone IJ; Gordon KA; Grewal IS; van Rooijen N; Law CL; Gerber HP
    Blood; 2007 Dec; 110(13):4370-2. PubMed ID: 17909075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
    Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma.
    Borchmann P; Treml JF; Hansen H; Gottstein C; Schnell R; Staak O; Zhang HF; Davis T; Keler T; Diehl V; Graziano RF; Engert A
    Blood; 2003 Nov; 102(10):3737-42. PubMed ID: 12881320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of adult T-cell leukemia with CD30 antigen expression.
    Ohtsuka E; Kikuchi H; Nasu M; Takita-Sonoda Y; Fujii H; Yokoyama S
    Leuk Lymphoma; 1994 Oct; 15(3-4):303-10. PubMed ID: 7866279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Haneji K; Matsuda T; Tomita M; Kawakami H; Ohshiro K; Uchihara JN; Masuda M; Takasu N; Tanaka Y; Ohta T; Mori N
    Nutr Cancer; 2005; 52(2):189-201. PubMed ID: 16201850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
    Cook LB; Taylor GP
    Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.
    Song Z; Wu W; Chen M; Cheng W; Yu J; Fang J; Xu L; Yasunaga JI; Matsuoka M; Zhao T
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines.
    Okudaira T; Hirashima M; Ishikawa C; Makishi S; Tomita M; Matsuda T; Kawakami H; Taira N; Ohshiro K; Masuda M; Takasu N; Mori N
    Int J Cancer; 2007 May; 120(10):2251-61. PubMed ID: 17278100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.
    Nakajima S; Okuma K
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
    Takemoto S; Iwanaga M; Sagara Y; Watanabe T
    Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.